Jacobs Kevin J 4

What Happened
Kevin J. Jacobs, a director of Omega Healthcare Investors, received a restricted stock award of 6,125 shares on June 5, 2026. The grant was recorded at an acquisition value of $43.67 per share, for a total value of $267,479. This transaction is coded as an award/grant (A) rather than an open‑market purchase or sale.

Key Details

• Transaction date: 2026-06-05; filing date (Form 4): 2026-06-09 (timely — within the two business day filing window).
• Shares granted/acquired: 6,125; per-share value: $43.67; total value: $267,479.
• Shares owned after transaction: Not reported in the provided filing excerpt.
• Footnote: The grant is a Restricted Stock Grant Award Agreement that will vest on the date of the Company’s 2027 Annual Meeting (approximately one year from the grant) and will convert to common stock on a one-for-one basis.
• Transaction code: A (award/grant).

Context
Restricted stock awards to directors are a common form of compensation and typically vest over time; they do not represent an immediate market purchase or sale. Because these shares vest in about a year and convert 1:1 to common stock, they will only affect ownership if/when vesting occurs and the shares are issued. This filing reports the compensation grant and is informational rather than an immediate trading signal.